Literature DB >> 18556707

Interventions to control MRSA: high time for time-series analysis?

S Harbarth1, M H Samore.   

Abstract

Time-series methods are useful in quasi-experimental study designs in which rates of antibiotic-resistant infections are ascertained before and after an intervention. However, uncertainties remain regarding the use of time-series analysis as an appropriate research methodology for analysing the effect of infection control interventions and antibiotic policies on the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA). In particular, there is still a substantial gap in our understanding of what actually happens to MRSA incidence when a planned intervention is made on use of one or more antibiotic drug classes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556707     DOI: 10.1093/jac/dkn240

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.

Authors:  Lidia Kardas-Sloma; Pierre-Yves Boëlle; Lulla Opatowski; Didier Guillemot; Laura Temime
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

2.  Variations in outpatient antimicrobial use between and within countries: an ongoing mystery.

Authors:  B Huttner; S Harbarth
Journal:  Infection       Date:  2010-02       Impact factor: 3.553

Review 3.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 4.  Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.

Authors:  C Angebault; A Andremont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-27       Impact factor: 3.267

Review 5.  [Nosocomial infections: MRSA und CDAD as a challenge].

Authors:  W V Kern; M Dettenkofer
Journal:  Internist (Berl)       Date:  2009-06       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.